Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02297087 · ClinicalTrials.gov registry record · NA
Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment
A NA study, sponsored by Western Regional Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02297087: Clinical Trial NA study, sponsored by Western Regional Medical Center.
NCT02297087 is a NA study that was terminated before completion, run by Western Regional Medical Center. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02297087, a NA study, was terminated before completion, sponsored by Western Regional Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Aim 1 - Launch Pilot Study. In this aim, the investigators seek to launch a pilot study and enroll 12 eligible patients with advanced small cell lung cancer (SCLC) and to obtain the necessary tumor biopsies to yield sufficient DNA and RNA for Genome-Wide Sequencing (GWS). Aim 2 - Treatment Selection. Completion of this study aim will provide a new clinical paradigm in the treatment of SCLC such that each individual patient would be treated with a single-agent or combination therapy of commercially available agents that relates to particular target(s) that have been identified via GWS.
Interventions
- GENETIC Standard of care based on target(s) identified via GWS.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-10 |
| Phase | NA |
Why NCT02297087 stopped before completion
NCT02297087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Standard of care based on target(s) identified via GWS. is the first listed.
NCT02297087 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02297087 about?
NCT02297087 is a clinical study titled "Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment". Aim 1 - Launch Pilot Study. In this aim, the investigators seek to launch a pilot study and enroll 12 eligible patients with advanced small cell lung cancer (SCLC) and to obtain the necessary tumor biopsies to yield sufficient DNA and RNA for Genome-Wide Sequencing (GWS). Aim 2 - Treatment Selectio...
What is the current status of trial NCT02297087?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2014-10. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02297087?
The interventions under investigation include: Standard of care based on target(s) identified via GWS. (GENETIC).
Who is sponsoring clinical trial NCT02297087?
This trial is sponsored by Western Regional Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02297087's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia